Mylan NV (MYL)

MYL (NASDAQ:Drugs) EQUITY
$69.82
pos +0.00
+0.00%
Today's Range: 66.31 - 72.16 | MYL Avg Daily Volume: 6,568,500
Last Update: 04/17/15 - 3:59 PM EDT
Volume: 0
YTD Performance: 23.85%
Open: $0.00
Previous Close: $66.84
52 Week Range: $44.80 - $72.62
Oustanding Shares: 378,373,668
Market Cap: 25,288,604,101
6-Month Chart
TheStreet Ratings Grade for MYL
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 10 9 9
Moderate Buy 0 1 0 0
Hold 1 1 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.18 1.21 1.36 1.36
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 28.56
Price Earnings Comparisons:
MYL Sector Avg. S&P 500
28.56 28.60 27.96
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
24.67% 48.80% 207.96%
GROWTH 12 Mo 3 Yr CAGR
Revenue 11.70 0.26 0.08
Net Income 48.90 0.73 0.20
EPS 47.70 0.99 0.26
Earnings for MYL:
EBITDA 1.89B
Revenue 7.72B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (12/15) FY (12/16)
Average Estimate $0.76 $1.03 $4.16 $4.63
Number of Analysts 4 3 9 9
High Estimate $0.95 $1.12 $4.25 $4.83
Low Estimate $0.69 $0.92 $4.00 $4.37
Prior Year $0.66 $0.69 $3.56 $4.16
Growth Rate (Year over Year) 15.53% 49.28% 16.76% 11.28%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
These companies are the hottest thing going.
Recent activity has heated up and is creating shareholder value.
But rate jitters still persist in the U.S.
And four other things you need to know now.
The Fed minutes produced little fanfare.
Even the second-tier biotechs are taking off.
The ecstasy and the agony of M&A all in one day.
Here are healthcare stocks of all shares and sizes with strong charts.
A huge political headwind has been removed for this pharma.
It might be good for consumers, but not for the stock.

Columnist Conversations

The last setup in COST is considered a bust...If you saw any triggers you would have been stopped out and at t...
The 300+ drop in the DJIA, 28+ point decline in the S&P 500 and the almost 86 point plunge in the Nasdaq r...
The bearish divergence in the stock price of Berkshire Hathaway (BRK/B) and the S&P 500 index may have bee...
Once again Amazon Inc. (AMZN) heads into earnings at a critical-chart inflection point. This past Tuesday (Apr...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.